Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 04 Mar 2026 | Katri Teedumäe Cabinet member | Exchange of views on regulatory issues | SRC |
| 04 Mar 2026 | Axel Hellman Cabinet member | To exchange views on the implications of the Urban Waste Water Treatment Directive and of the proposed Universal PFAS Restriction. | — |
| 04 Mar 2026 | Katri Teedumäe Cabinet member | Exchange of views on regulatory issues | — |
| 04 Mar 2026 | Karolina Tomaszewska-Boillot Cabinet member | Exchange of views on regulatory issues | — |
| 04 Mar 2026 | Olivér Várhelyi Commissioner | Exchange of views on regulatory issues | — |
| 04 Mar 2026 | Patricia Reilly Cabinet member | Exchange of views on the EU initiatives shaping the regulatory framework for companies operating in the healthcare field | SRC |
| 04 Mar 2026 | Olivér Várhelyi Commissioner | Exchange of views on regulatory issues | SRC |
| 04 Mar 2026 | Axel Hellman Cabinet member | To exchange views on the implications of the Urban Waste Water Treatment Directive and of the proposed Universal PFAS Restriction. | SRC |
| 04 Mar 2026 | Jana Dabbelt Cabinet member | Exchange of views on regulatory issues | SRC |
| 04 Mar 2026 | Karolina Tomaszewska-Boillot Cabinet member | Exchange of views on regulatory issues | SRC |
| 04 Mar 2026 | Patricia Reilly Cabinet member | Exchange of views on the EU initiatives shaping the regulatory framework for companies operating in the healthcare field | — |
| 09 Dec 2025 | Miguel Jose Garcia Jones Cabinet member | F-Gas Regulation | — |
| 09 Dec 2025 | Miguel Jose Garcia Jones Cabinet member | F-Gas Regulation | SRC |
| 29 Sept 2025 | Patricia Reilly Cabinet member | exchange on critical needs for EU crisis preparedness | — |
| 29 Sept 2025 | Florika Fink-Hooijer Director-General | Presentation of the company | — |
| 29 Sept 2025 | Katri Teedumäe Cabinet member | Challenges related safe medicines supply | SRC |
| 29 Sept 2025 | Katri Teedumäe Cabinet member | Challenges related safe medicines supply | — |
| 29 Sept 2025 | Patricia Reilly Cabinet member | exchange on critical needs for EU crisis preparedness | SRC |
| 29 Sept 2025 | Florika Fink-Hooijer Director-General | Presentation of the company | SRC |
| 26 Feb 2015 | Annika Nowak Cabinet member | Blood directive | SRC |
| 26 Feb 2015 | Annika Nowak Cabinet member | Blood directive | — |
Mission & Goals
Baxter’s mission to save and sustain lives inspires our work and our commitment to deliver products and services that are essential building blocks of healthcare. Baxter touches millions of lives every day. Our products can be found in almost every hospital worldwide, in clinics and in the home. Patients and healthcare providers rely on Baxter for lifesaving therapies, as well as medical products, focused on offering advanced technology for the hospital and outpatient sites of care, including infusion systems, smart beds, clinical nutrition, surgical tools, injectable medicines, diagnostic tools and connected care solutions. Our mission to save and sustain lives inspires our work and our commitment to expanding access to care, providing cost-effective healthcare solutions, delivering quality products and advancing innovations for the world.
EU Legislative Interests
EU initiatives, policies and legislative files related to the field of healthcare policy including sector specific and horizontal legislation, crisis preparedness and healthcare resilience, sustainability, digital health and patient access
Communication Activities
EU initiatives, policies and legislative files related to the field of healthcare policy including sector specific and horizontal legislation, crisis preparedness and healthcare resilience, sustainability, digital health and patient access
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
MedTech Europe, MNI (Medical Nutrition Industry), Medicines for Europe, Europen
Organisation Members
https://www.baxter.com/location-selector